TSS:Hg 131418.1

Basic information about the TSS

---

TSS ID: hg_131418.1 Species: human Chr: chr12		Start: 55727019 End: 55727030 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000548160.5 Distance: -29 GeneID: 967 HGNC/MGI_ID: HGNC:1692 UniProt_ID: F8VV56

Gene_name: CD63 molecule Gene_symbol: CD63 Gene_synonyms: ME491 TSPAN30 Gene_source: HGNC:1692

TATA-Box annotation

---

Distance to TSS:	763
Nearest PromoterID:	NM_001257401
Entrez ID:	967
Nearest Unigene:	Hs.445570
Nearest Refseq:	NM_001780
Nearest Ensembl:	ENSG00000135404
Gene Name:	CD63 molecule
Gene Alias:	LAMP-3|ME491|MLA1|OMA81H|TSPAN30
Gene Description:	CD63 molecule
Gene Type:	protein-coding
CpG%:	0.02
GC%:	0.562189
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CD63 p2@CD63 p4@CD63 p5@CD63 p10@CD63
Sample		p1@CD63	p2@CD63	p4@CD63	p5@CD63	p10@CD63
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	66.43	0.19	0.00	4.68	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	76.68	1.21	0.00	3.24	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	73.50	0.77	0.00	3.09	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	68.19	1.04	0.21	2.29	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	74.01	0.90	0.00	2.47	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	63.96	1.74	0.00	3.10	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	93.04	1.09	0.22	6.32	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	83.08	0.24	0.24	2.42	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	100.87	1.28	0.64	4.27	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.73	0.58	0.00	4.64	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	39.21	0.00	0.00	7.68	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.03	0.41	0.41	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	240.98	8.38	1.29	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	206.43	10.98	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	196.28	9.88	1.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	173.53	6.04	0.50	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	166.21	9.83	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	156.92	8.44	1.27	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	155.68	4.27	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	277.56	15.19	1.05	1.50	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	236.56	11.36	1.20	1.07	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	253.24	12.60	1.55	0.69	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	194.40	10.21	1.03	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	198.26	10.92	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	196.59	12.38	1.03	0.77	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	247.20	9.81	0.95	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	184.07	14.29	1.65	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	286.44	11.55	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	257.15	11.63	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	263.85	11.04	2.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	235.30	12.77	1.88	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	257.12	13.87	0.98	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	218.63	11.18	0.84	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	245.60	13.53	2.14	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	247.01	8.98	0.75	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	231.48	10.92	0.96	0.00	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	285.93	11.85	1.64	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	211.36	11.48	1.81	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	246.60	10.53	1.62	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	246.54	11.04	1.68	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	223.73	10.35	0.94	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	246.82	12.00	2.20	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	216.80	13.71	1.27	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	252.10	8.57	1.92	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	251.57	9.24	1.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	282.67	12.33	2.56	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	237.27	8.16	1.20	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	287.92	11.03	1.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	256.85	11.25	1.44	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	280.04	10.92	1.21	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	226.68	12.30	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	256.40	12.68	1.78	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	265.85	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	152.94	4.26	1.06	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	160.39	8.28	0.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	269.30	15.94	3.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	284.73	15.61	1.38	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	155.90	8.75	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	148.38	6.10	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	320.93	11.94	1.57	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	124.79	3.53	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	130.66	4.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	281.83	8.76	0.00	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	275.55	8.49	0.68	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	149.46	5.52	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	143.06	3.19	1.06	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	290.95	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	481.75	15.79	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	175.51	3.41	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	199.34	2.98	1.49	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	190.93	4.69	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	439.82	5.63	3.97	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	225.82	2.78	2.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	234.20	5.50	2.14	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	452.98	6.49	1.74	5.39	0.32
Adipocyte - breast, donor2	11327-117E4	483.85	3.05	2.57	2.41	2.25
Adipocyte - omental, donor1	11473-119C6	526.72	5.60	2.04	3.18	1.27
Adipocyte - omental, donor2	11474-119C7	725.82	3.74	2.24	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	755.91	7.70	0.33	1.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	876.60	10.85	0.00	4.47	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	382.63	4.40	1.10	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	545.56	9.03	0.45	1.81	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	779.04	6.08	4.00	3.82	3.48
Adipocyte differentiation, day04, donor1	13019-139D4	997.03	10.76	4.50	1.96	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	543.33	6.95	3.60	0.26	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	851.65	8.64	3.62	2.51	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	608.38	1.18	2.94	4.11	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	706.77	2.41	1.69	3.86	1.85
Adipocyte differentiation, day08, donor2	13023-139D8	671.65	6.46	3.87	2.26	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	582.24	1.60	3.73	3.73	4.80
Adipocyte differentiation, day08, donor4	13029-139E5	408.42	1.67	1.67	2.23	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	716.17	5.41	1.66	1.25	2.91
Adipocyte differentiation, day12, donor2	13024-139D9	568.89	4.02	4.02	3.52	2.26
Adipocyte differentiation, day12, donor3	13027-139E3	478.11	3.93	3.27	3.27	3.27
Adipocyte differentiation, day12, donor4	13030-139E6	430.22	1.52	1.22	2.44	3.04
Alveolar Epithelial Cells, donor1	11510-119G7	411.50	6.85	3.09	1.33	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	643.30	11.12	3.59	0.00	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	368.99	3.59	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	378.88	5.04	1.62	1.80	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	396.62	11.71	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	417.06	4.11	2.05	1.85	0.62
Anulus Pulposus Cell, donor1	11248-116E6	532.65	17.96	3.89	0.69	1.37
Anulus Pulposus Cell, donor2	11463-119B5	623.29	14.69	2.94	0.98	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	376.51	6.74	4.04	0.90	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	412.87	5.21	4.78	1.74	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	365.98	6.42	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	380.53	4.18	3.59	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	490.68	6.32	7.59	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	314.19	6.60	3.30	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	386.94	5.52	1.95	0.65	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	439.81	10.19	3.40	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	318.32	5.94	2.38	2.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	369.86	8.29	4.14	1.88	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	363.56	6.53	7.26	2.18	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	336.01	13.79	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	408.38	7.58	6.10	2.47	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	375.32	9.55	1.36	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	394.32	6.18	2.11	1.81	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	393.27	8.04	3.75	1.07	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	451.37	5.67	4.53	1.32	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	296.95	5.61	2.14	2.14	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	322.87	6.83	5.85	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	454.29	6.80	4.15	1.00	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	313.39	4.80	6.00	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	265.51	10.62	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	427.11	5.49	4.80	1.20	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	285.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	416.98	5.34	2.43	0.97	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	462.93	7.97	1.90	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	313.74	6.06	7.27	0.00	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	418.98	3.99	2.85	1.71	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	458.76	5.99	3.42	1.28	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	307.38	7.23	3.61	1.29	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	373.96	6.10	3.75	0.94	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	395.51	4.50	4.18	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	367.43	6.42	2.14	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	369.10	6.43	5.26	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	436.25	6.62	3.01	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	381.34	11.88	4.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	437.36	7.12	2.54	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	436.03	5.35	3.06	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	336.11	4.45	2.54	1.91	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	383.63	6.04	3.02	2.59	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	427.18	6.56	4.02	1.27	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	288.82	8.12	2.32	1.45	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	347.66	3.78	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	431.10	4.92	3.56	0.68	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	280.28	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	310.55	8.45	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	434.40	6.43	3.22	1.50	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	265.94	4.81	3.01	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	400.21	6.56	2.92	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	505.51	8.74	3.45	2.99	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	313.69	15.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	432.96	5.59	4.58	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	457.47	8.26	3.72	0.83	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	310.90	5.20	2.45	3.06	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	393.40	7.65	5.74	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	443.70	6.43	2.88	1.11	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	364.67	4.58	1.53	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	406.00	7.75	0.55	1.66	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	408.31	5.56	3.97	2.38	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	302.75	6.18	2.18	1.45	0.73
Astrocyte - cerebellum, donor1	11500-119F6	456.02	18.18	0.37	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	598.89	15.06	1.03	0.51	0.51
Astrocyte - cerebellum, donor3	11661-122F5	369.37	15.31	2.10	0.63	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	309.54	10.81	0.00	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	329.21	6.47	1.62	1.78	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	352.61	7.16	1.04	0.60	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	53.10	0.34	0.11	1.72	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	51.37	0.25	0.13	1.50	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	53.14	0.34	0.00	2.28	0.11
Basophils, donor1	12241-129G9	315.93	1.57	0.26	2.09	0.52
Basophils, donor2	12242-129H1	209.26	2.53	0.72	1.44	0.00
Basophils, donor3	12243-129H2	248.57	0.59	0.59	3.09	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	200.08	5.17	1.08	2.16	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	411.47	13.72	3.20	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	179.34	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	239.76	8.79	1.26	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	295.71	3.74	1.46	0.83	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	211.87	5.76	0.69	0.92	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	176.35	6.12	0.54	1.08	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	21.02	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	39.59	0.47	0.00	1.40	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	110.32	7.99	0.64	0.96	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	175.81	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	178.08	1.13	1.13	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	118.41	0.93	0.00	1.67	0.19
CD14+ Monocytes, donor3	11381-118B4	134.14	0.66	0.44	1.10	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	1248.51	17.55	10.19	1.70	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1475.36	10.24	15.92	0.00	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	1483.61	15.78	10.52	1.31	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	351.83	2.31	0.72	4.34	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	282.13	2.11	1.51	2.11	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	282.85	0.71	1.42	1.42	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	337.98	1.51	1.51	2.68	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	361.85	1.93	0.83	3.59	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	426.44	1.98	0.74	3.97	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	378.09	1.76	1.37	7.05	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	307.49	1.60	1.25	4.45	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	472.48	2.18	1.31	8.05	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	290.55	1.40	0.47	2.58	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	263.49	2.11	0.53	2.11	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	275.12	0.00	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	341.53	2.23	0.30	3.42	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	360.78	2.20	1.60	2.79	1.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	474.90	2.50	0.42	4.16	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	399.23	2.52	0.69	2.75	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	328.90	2.04	0.68	2.94	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	271.04	0.44	1.31	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	357.22	1.08	0.81	5.65	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	324.67	1.74	1.05	4.71	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	302.99	1.26	0.84	4.63	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	345.01	2.20	0.18	2.76	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	358.61	2.47	0.70	1.06	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	282.10	1.32	0.00	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	388.51	1.92	1.22	6.97	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	300.69	1.49	2.60	5.20	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	518.40	3.88	1.94	8.84	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	286.23	1.64	1.23	2.46	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	287.89	0.70	0.00	1.39	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	273.98	1.16	0.00	1.62	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	113.12	1.31	0.00	1.74	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	125.66	0.92	0.92	0.92	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	120.44	1.30	0.22	2.38	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	160.71	0.93	0.31	3.43	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	143.03	0.52	0.52	1.92	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	149.61	0.45	0.22	2.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	91.10	2.55	0.26	2.30	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	58.40	1.98	0.22	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	42.53	1.47	0.63	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	39.32	0.68	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	39.35	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	51.17	0.53	0.00	4.26	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	40.21	0.00	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	45.63	0.70	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	41.57	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	44.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	18.90	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	21.04	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	18.17	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	75.56	1.21	0.40	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	67.11	0.40	0.00	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	99.40	5.02	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	204.50	3.93	1.69	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	130.39	5.26	0.75	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	172.27	9.02	1.58	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	11.78	1.43	0.00	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	18.37	1.22	0.00	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	19.82	1.22	0.00	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	25.78	0.77	0.26	1.53	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.99	0.67	0.00	1.80	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	25.87	1.15	0.00	2.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	18.96	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.99	2.11	0.00	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	46.10	1.59	0.87	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.42	1.02	0.68	2.20	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	39.01	0.64	0.48	2.10	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	19.28	0.45	0.45	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.60	1.75	0.35	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.12	1.76	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	33.73	2.11	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.67	2.91	0.62	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	52.46	2.34	1.00	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	8.70	1.36	0.00	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	7.50	1.07	0.00	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	47.66	1.67	0.56	1.67	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	50.47	0.22	0.22	2.60	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.49	1.89	0.42	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	24.27	0.51	0.00	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.46	4.77	0.00	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	25.71	0.87	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	84.62	1.48	0.00	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	96.93	1.85	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	114.46	2.79	0.00	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	98.03	4.15	0.00	1.66	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	118.03	3.93	0.49	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	90.86	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	104.57	1.07	0.72	2.15	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	146.81	2.77	0.00	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	34.38	0.65	0.33	0.33	0.65
CD8+ T Cells, donor2	11307-117C2	40.17	0.38	0.00	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	31.81	0.50	0.00	1.01	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	44.04	0.00	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	40.02	0.48	0.24	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	0.27	0.00	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	48.63	0.30	0.00	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.28	0.48	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	47.75	0.23	0.23	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	41.72	0.22	0.00	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.85	1.05	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	42.21	0.23	0.00	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	39.55	0.00	0.00	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.41	0.00	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.03	0.27	0.53	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	38.08	0.88	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	39.17	0.91	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	39.53	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	57.26	0.00	0.00	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.62	0.00	0.29	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	42.43	0.24	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	56.73	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	50.44	0.62	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	46.16	0.00	0.00	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	39.39	0.38	0.76	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	39.41	0.39	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	0.80	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.28	0.70	0.00	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	588.53	9.14	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	278.17	7.41	2.47	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	322.12	5.47	1.47	1.89	0.21
Chondrocyte - de diff, donor1	11261-116G1	613.25	11.79	1.04	0.35	1.04
Chondrocyte - de diff, donor2	11338-117F6	497.17	8.53	1.42	2.49	0.00
Chondrocyte - de diff, donor3	11410-118E6	496.30	9.33	2.05	2.96	0.34
Chondrocyte - re diff, donor2	11339-117F7	708.15	24.17	2.69	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	622.78	21.43	5.26	4.04	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	340.95	18.48	2.87	1.03	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	283.45	14.96	1.92	1.28	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	291.07	12.92	2.57	0.80	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	245.30	6.51	0.55	4.13	0.18
Corneal Epithelial Cells, donor1	11526-119I5	224.18	5.71	1.32	1.54	0.00
Corneal Epithelial Cells, donor2	11606-120I4	87.60	6.83	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	163.86	5.37	1.28	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	473.99	6.44	13.70	0.66	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	520.43	8.83	14.19	1.26	3.47
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	503.80	3.45	27.61	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	556.25	10.69	21.38	0.22	2.48
Dendritic Cells - plasmacytoid, donor1	11228-116C4	56.37	1.37	0.34	2.05	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	73.77	0.65	0.00	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	82.75	0.48	0.48	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	409.75	5.67	1.17	1.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	407.81	6.45	1.76	3.52	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	568.71	4.81	1.70	1.70	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	499.74	8.26	1.97	1.18	0.39
Endothelial Cells - Artery, donor1	11264-116G4	414.20	5.24	1.75	1.45	0.29
Endothelial Cells - Artery, donor2	11341-117F9	235.98	3.29	0.94	3.06	0.24
Endothelial Cells - Artery, donor3	11413-118E9	308.54	3.33	1.23	1.93	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	425.79	6.21	1.33	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	483.48	6.39	2.74	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	411.02	3.66	1.13	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	419.55	3.86	1.19	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	500.36	5.73	1.56	4.69	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	332.63	3.26	0.71	2.27	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	369.71	4.80	1.20	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	393.09	3.14	3.67	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	269.49	4.47	1.12	1.12	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	288.52	2.39	0.43	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	328.28	1.71	0.98	0.98	0.12
Endothelial Cells - Vein, donor1	11267-116G7	356.04	2.28	0.00	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	361.12	6.29	0.70	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	372.11	4.08	2.83	1.88	0.16
Eosinophils, donor1	12244-129H3	396.42	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	844.93	0.00	0.00	3.30	1.65
Eosinophils, donor3	12246-129H5	834.64	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	183.00	7.33	1.22	0.98	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	149.77	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	474.97	13.96	4.11	2.87	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	468.50	8.87	4.71	0.55	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	83.53	1.95	1.52	1.73	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	439.28	8.97	4.00	1.94	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	522.41	9.14	6.41	1.36	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	567.32	7.28	6.86	1.27	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1329.31	18.97	5.80	1.32	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	523.21	4.98	4.98	1.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	385.13	4.08	3.18	3.63	0.91
Fibroblast - Cardiac, donor2	11345-117G4	356.24	6.06	1.52	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	494.12	8.36	5.84	4.26	0.63
Fibroblast - Cardiac, donor4	11452-119A3	486.18	2.42	2.12	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	460.41	6.35	1.78	1.40	0.38
Fibroblast - Cardiac, donor6	11460-119B2	469.79	5.46	2.88	0.61	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	792.55	10.05	0.67	1.07	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	400.37	3.88	2.16	0.00	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	237.30	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	478.81	11.30	2.31	2.54	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	635.17	11.02	3.56	1.02	1.87
Fibroblast - Dermal, donor1	11269-116G9	556.67	5.87	6.10	0.23	2.58
Fibroblast - Dermal, donor2	11346-117G5	624.97	3.77	6.13	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	661.13	9.55	6.29	0.48	0.97
Fibroblast - Dermal, donor4	11450-119A1	360.50	4.86	2.03	0.68	0.11
Fibroblast - Dermal, donor5	11454-119A5	359.72	4.01	1.57	1.57	0.17
Fibroblast - Dermal, donor6	11458-119A9	430.42	6.01	1.95	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	568.47	11.87	4.37	0.21	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	479.98	6.29	1.57	2.36	0.79
Fibroblast - Gingival, donor2	11318-117D4	416.04	12.52	2.24	0.66	0.26
Fibroblast - Gingival, donor3	11394-118C8	588.24	8.51	3.09	1.26	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	1011.88	18.70	4.16	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	604.20	5.29	3.35	3.17	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	502.77	8.11	2.96	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	544.16	8.38	4.60	0.95	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	454.51	1.76	1.41	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	566.70	7.31	2.63	0.73	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	442.60	9.82	2.05	1.50	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	565.36	5.70	2.08	0.55	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	803.40	8.07	1.61	3.23	0.59
Fibroblast - Lung, donor1	11270-116H1	406.45	8.16	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	304.40	1.49	2.98	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	511.55	8.23	5.49	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	1254.53	20.83	0.83	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	727.29	4.20	2.80	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	637.28	11.20	7.00	0.56	0.84
Fibroblast - Mammary, donor1	11540-120B1	774.59	6.90	4.47	1.62	0.81
Fibroblast - Mammary, donor2	11620-122A9	523.24	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	810.05	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	459.14	15.32	2.52	1.16	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	379.36	7.58	2.43	0.46	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	543.43	6.73	2.75	1.22	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	702.19	5.34	2.67	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	710.34	8.10	7.29	2.16	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	746.18	4.52	3.83	2.55	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	391.29	6.63	2.87	1.99	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	708.12	10.57	5.89	1.42	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	632.12	8.69	2.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	538.09	7.12	3.56	1.58	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	551.49	10.72	0.60	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	750.26	4.44	1.78	3.02	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	679.55	5.72	1.38	1.18	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	955.21	10.53	1.50	0.90	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	871.92	8.64	2.59	1.40	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	454.02	9.11	1.01	1.27	0.25
Fibroblast - skin normal, donor1	11553-120C5	855.50	13.29	2.30	2.13	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	960.03	9.62	4.21	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	780.99	10.55	1.61	1.00	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	366.92	5.44	1.21	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	534.85	3.73	1.99	2.49	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	825.35	9.23	1.88	1.03	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1031.93	10.18	1.31	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	873.37	11.08	1.81	0.64	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	581.61	9.78	2.36	1.01	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	745.83	9.25	2.98	3.76	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	731.27	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	55.78	0.87	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	350.36	3.47	3.81	2.43	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	332.33	2.60	2.60	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	314.02	4.09	2.04	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	231.96	5.36	0.77	3.83	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	194.61	6.38	0.64	8.29	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	355.72	7.13	0.86	3.99	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	265.28	8.55	1.10	2.48	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	151.15	9.82	0.46	1.60	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	268.86	7.13	0.79	3.17	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	201.42	6.08	0.79	2.11	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	136.66	9.13	0.98	3.59	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	293.19	7.08	0.44	2.65	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	323.20	4.80	1.13	3.96	3.39
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	323.74	6.03	1.11	2.59	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	311.61	2.69	1.07	5.91	3.76
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	394.35	3.84	2.48	1.73	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	524.91	4.01	2.35	1.52	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	420.43	2.64	2.64	2.85	3.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	349.11	10.72	2.97	2.28	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	458.78	7.85	3.36	2.24	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	531.58	6.78	2.84	1.97	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	335.37	8.27	2.07	2.36	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	355.75	9.22	2.07	2.54	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	453.77	5.81	3.35	4.69	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	337.53	10.69	1.41	3.43	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	377.79	15.61	2.54	1.87	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	384.84	12.15	3.90	3.10	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	267.84	12.59	1.66	3.12	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	265.73	10.08	1.02	1.54	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	406.21	17.93	2.99	1.88	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	379.62	13.39	3.58	4.33	1.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	372.22	11.84	1.63	3.27	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	342.88	12.79	2.27	3.09	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	353.95	13.37	3.11	3.46	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	509.80	13.01	5.17	3.00	1.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	355.55	13.67	3.53	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	496.52	18.45	2.95	3.07	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	424.68	13.13	4.86	3.40	1.46
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	348.30	11.55	0.96	4.17	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	467.14	21.79	3.22	1.99	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	503.16	17.08	6.49	2.37	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	435.76	21.29	2.74	4.56	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	536.60	22.58	3.03	2.09	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	578.31	14.93	6.59	3.07	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	436.53	14.59	2.24	3.09	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	527.01	22.31	4.81	2.31	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	569.30	17.11	6.15	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	556.17	24.79	6.12	2.60	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	636.41	29.53	8.29	2.46	2.20
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	737.05	15.18	7.32	2.44	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	553.42	14.01	2.95	3.32	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	548.50	10.97	2.19	3.29	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	577.20	4.96	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	468.02	9.50	3.17	2.64	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	525.98	9.48	1.61	1.21	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	308.04	5.08	1.27	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	306.15	4.98	0.80	3.18	2.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	283.50	2.00	0.77	2.93	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	229.54	2.05	0.20	4.09	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	208.41	1.88	0.31	3.44	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	183.10	2.26	0.57	3.39	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	146.66	0.92	0.46	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	205.41	2.47	0.00	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	237.89	2.71	1.16	5.03	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	234.25	1.60	0.00	3.21	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	210.40	6.96	1.74	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	231.74	5.53	1.30	4.23	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	237.20	2.88	0.82	1.65	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	129.96	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	208.62	2.80	0.28	4.75	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	218.99	1.96	1.96	4.25	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	142.60	1.68	0.00	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	201.66	3.18	0.00	2.23	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	195.31	1.70	0.68	2.72	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	227.61	4.18	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	187.27	3.44	0.57	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	186.77	2.37	1.18	3.55	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	238.87	5.08	0.00	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	245.21	4.14	0.83	4.14	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	183.41	5.75	0.23	2.30	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	268.69	0.00	5.27	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	196.43	4.61	0.77	4.23	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	212.86	3.91	0.33	2.93	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	250.81	4.68	0.67	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	208.82	4.62	1.54	4.24	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	241.69	4.79	1.03	3.08	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	188.84	7.45	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	221.30	3.77	0.00	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	208.81	6.64	1.21	4.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	216.19	5.09	0.51	3.56	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	183.47	2.79	0.40	3.59	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	259.01	6.41	1.48	3.95	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	260.88	5.90	1.18	7.08	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	210.62	8.17	1.17	5.25	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	251.92	5.71	0.44	6.58	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	178.02	5.09	0.85	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	190.42	7.16	0.60	7.76	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	252.33	8.25	0.97	2.91	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	553.53	9.13	6.85	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	424.96	10.40	3.33	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	684.79	11.24	3.37	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	398.67	5.07	3.81	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	573.56	10.44	6.27	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	176.04	5.34	1.39	1.16	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	148.55	4.39	2.87	1.52	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	160.16	4.78	2.28	0.91	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	168.55	5.79	3.28	2.19	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	155.17	6.23	1.50	2.58	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	148.54	5.17	2.58	1.72	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	173.61	6.10	3.36	1.62	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	143.42	6.35	2.06	1.20	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	156.34	4.81	3.52	1.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	428.11	5.60	1.12	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	473.48	6.06	3.46	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	346.34	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	538.61	13.76	1.41	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	544.16	13.80	4.36	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	377.13	8.04	2.62	0.87	0.35
Hepatocyte, donor1	11523-119I2	159.80	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	291.96	0.00	2.15	6.46	0.00
Hepatocyte, donor3	11684-122I1	298.18	3.07	0.61	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	0.00	0.00	2.61	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	261.65	7.34	1.22	3.85	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	431.79	12.35	2.74	0.69	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	171.93	3.18	6.37	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	146.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	150.90	0.00	0.00	5.54	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	115.12	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	261.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	153.77	0.00	2.56	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	141.69	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	201.42	1.62	1.62	4.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	160.06	1.67	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	72.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	173.37	0.00	0.00	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	159.64	0.00	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	130.96	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	146.76	0.63	1.89	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	154.66	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	150.53	0.65	0.65	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	151.33	0.00	6.44	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	167.86	1.63	0.00	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	152.81	1.26	1.68	3.78	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	170.38	0.00	0.00	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	150.49	0.00	3.69	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	150.11	0.47	1.42	1.42	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	143.30	3.63	0.91	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	140.97	1.08	3.23	3.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	163.89	0.00	1.27	5.08	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	135.83	0.00	1.28	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	165.86	1.82	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	136.39	2.14	2.86	2.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	152.64	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	156.49	0.62	1.85	2.78	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	163.31	0.00	0.00	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	194.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	162.72	1.39	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	159.34	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	145.89	0.00	0.00	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	149.10	0.00	0.87	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	161.98	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	132.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	145.08	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	156.56	0.00	0.00	4.16	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	88.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	136.22	0.92	0.92	4.60	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	169.42	0.00	3.03	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	149.01	0.00	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	131.11	1.06	0.00	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	127.29	1.63	0.90	2.20	0.00
Keratinocyte - epidermal, donor2	11349-117G8	130.60	2.93	0.00	2.34	0.00
Keratinocyte - epidermal, donor3	11421-118F8	152.96	3.03	1.04	2.18	0.19
Keratinocyte - oral, donor1	11251-116E9	180.61	9.76	1.02	1.70	0.00
Keratocytes, donor1	11527-119I6	669.10	25.79	4.13	0.69	1.38
Keratocytes, donor2	11607-120I5	528.48	15.23	4.69	0.00	0.00
Keratocytes, donor3	11688-122I5	390.85	11.07	2.96	2.17	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	417.60	15.39	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	156.42	5.39	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	514.26	13.49	1.27	0.58	0.69
Lens Epithelial Cells, donor3	11690-122I7	561.66	13.42	2.12	2.02	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	357.51	3.79	1.42	1.66	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	245.31	2.51	2.23	2.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	251.70	2.83	1.89	1.42	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	246.27	4.84	1.08	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	255.28	2.52	0.63	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	277.41	3.67	1.29	1.94	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	193.29	3.28	0.82	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	314.00	3.79	1.52	2.78	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	246.88	3.52	1.41	1.69	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	242.86	3.56	0.40	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	292.57	1.74	1.16	2.13	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	306.24	5.18	0.93	1.67	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	242.85	3.14	1.74	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	273.35	4.29	0.72	2.15	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	280.19	3.57	1.24	1.51	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	263.92	5.54	1.85	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	253.76	4.36	1.25	2.18	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	276.86	2.56	1.65	2.20	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	231.36	2.96	2.63	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	263.00	7.32	0.88	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	277.80	6.22	1.00	1.99	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	235.69	2.91	0.00	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	275.76	4.04	1.62	2.96	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	268.70	6.06	1.21	2.27	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	229.66	5.70	1.04	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	281.21	2.72	0.63	1.26	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	289.62	3.46	1.95	2.26	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	256.58	6.19	0.69	2.06	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	324.18	3.57	1.32	3.01	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	296.88	4.03	1.91	1.06	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	226.78	4.85	1.94	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	284.81	3.97	2.32	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	279.75	3.72	1.49	1.73	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	267.66	3.70	1.85	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	276.98	4.45	1.24	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	287.91	5.36	1.24	2.06	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	238.01	2.89	0.96	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	281.81	4.26	1.52	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	298.27	4.20	1.68	2.10	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	261.34	2.49	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	290.87	2.91	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	311.84	4.98	1.24	2.18	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	271.44	5.01	2.86	1.79	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	314.59	3.92	0.98	3.27	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	284.39	3.30	1.65	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	368.66	3.84	1.36	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	330.66	6.40	1.54	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	319.84	2.69	0.30	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	444.14	18.13	2.27	6.80	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	296.11	5.37	1.53	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	262.75	9.65	0.00	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	228.91	9.73	0.00	2.96	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	258.82	9.85	3.52	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	268.98	10.27	0.00	0.93	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	183.44	6.70	2.06	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	285.47	8.33	2.38	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	271.21	12.67	3.39	5.20	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	216.08	8.72	3.20	2.91	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	256.60	6.30	1.80	3.60	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	258.37	10.03	2.57	4.47	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	254.71	8.22	2.57	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	257.94	9.17	2.47	4.59	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	213.22	2.67	0.67	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	207.83	10.70	3.57	4.08	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	291.35	7.47	4.80	2.13	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	309.30	7.75	2.27	3.78	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	232.54	6.14	1.23	7.98	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	313.94	8.97	2.45	2.45	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	289.46	7.08	2.71	3.12	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	239.90	8.41	2.80	2.80	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	294.68	2.06	3.09	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	298.14	9.29	2.61	2.90	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	230.77	10.46	1.49	2.09	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	288.25	9.41	2.21	3.32	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	304.35	10.60	3.89	3.53	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	224.96	8.11	1.84	2.21	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	309.69	6.91	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	303.93	8.44	3.45	4.22	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	211.73	7.36	2.26	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	278.96	7.38	0.82	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	274.29	7.68	3.16	2.26	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	234.83	12.93	2.15	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	292.04	11.20	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	297.65	11.89	3.72	2.60	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	230.88	13.78	3.88	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	332.24	11.99	2.57	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	311.52	10.66	3.00	3.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	243.13	9.05	1.81	1.81	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	335.59	10.66	1.42	4.98	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	280.13	14.44	3.44	4.47	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	253.88	10.73	2.68	2.68	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	292.91	7.41	2.69	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	292.99	8.89	4.07	2.96	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	476.80	19.77	3.49	5.81	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	290.88	12.69	1.06	4.23	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	275.70	7.60	2.80	4.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	212.25	13.81	2.18	3.63	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	336.50	15.33	3.07	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	285.11	7.40	3.95	5.43	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	168.43	8.47	2.82	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	323.82	10.06	2.01	10.06	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	251.45	9.46	1.80	4.51	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	185.88	8.61	0.00	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	310.40	10.69	2.67	5.79	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	264.33	9.78	1.56	6.65	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	248.72	10.56	3.30	3.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	323.81	11.94	1.04	7.26	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	255.10	5.69	0.44	3.94	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	242.09	13.42	1.68	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	311.36	7.07	3.53	5.30	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	321.30	10.41	2.70	4.24	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	253.18	8.61	2.03	3.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	291.26	9.61	5.77	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	277.49	10.73	1.99	3.18	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	240.62	10.33	1.82	2.43	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	237.25	5.53	0.00	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	303.99	7.60	3.42	5.70	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	234.97	9.81	1.03	4.13	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	271.49	7.86	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	289.96	9.19	1.27	3.80	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	228.70	9.60	1.60	2.13	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	294.81	12.64	0.57	0.57	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	307.51	7.20	3.60	4.11	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	236.26	8.49	0.71	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	309.85	7.94	0.57	2.27	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	284.56	7.90	2.50	6.66	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	247.44	9.40	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	313.16	11.69	1.67	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	308.52	12.08	1.86	2.79	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	258.92	8.70	0.67	5.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	330.94	10.16	1.07	4.28	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	293.78	9.70	2.42	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	242.29	15.60	2.75	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	280.96	6.22	1.78	2.67	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	304.31	7.98	4.56	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	244.64	5.37	1.53	2.30	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	263.74	8.21	2.19	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	301.57	8.46	2.23	3.56	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	301.29	13.78	3.12	4.16	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	309.01	9.95	1.99	3.32	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	311.79	10.39	0.00	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	942.66	9.80	7.52	1.37	0.23
Macrophage - monocyte derived, donor2	11313-117C8	1158.48	12.66	27.53	1.10	3.12
Macrophage - monocyte derived, donor3	11389-118C3	929.23	7.34	23.59	0.66	1.70
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	492.26	5.31	5.31	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	370.94	3.01	1.43	1.90	0.00
Mallassez-derived cells, donor3	11930-125I4	313.83	2.08	0.69	1.53	0.00
Mammary Epithelial Cell, donor1	11273-116H4	211.34	4.88	1.99	3.99	0.50
Mammary Epithelial Cell, donor2	11350-117G9	197.18	4.63	1.74	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	188.57	2.74	2.74	2.00	0.25
Mast cell - stimulated, donor1	11487-119E2	1030.46	20.34	5.42	0.00	0.68
Mast cell, donor1	11563-120D6	1424.21	32.87	10.27	0.97	2.05
Mast cell, donor2	11565-120D8	812.18	9.51	2.08	0.89	1.78
Mast cell, donor3	11566-120D9	816.75	10.36	5.85	1.80	1.58
Mast cell, donor4	11567-120E1	732.03	4.96	2.48	1.06	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	1184.56	22.29	7.21	0.67	3.99
Mast cell, expanded and stimulated, donor8	11942-126A7	414.41	15.18	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	1326.19	28.11	7.92	0.80	1.72
Mast cell, expanded, donor8	11941-126A6	608.88	16.57	4.18	0.67	1.00
Melanocyte - dark, donor1	11502-119F8	314.91	4.97	0.99	1.29	0.10
Melanocyte - dark, donor2	11582-120F7	302.82	5.88	2.42	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	1258.66	20.86	7.24	0.80	2.54
Melanocyte - light, donor1	11274-116H5	830.27	24.21	6.11	1.18	1.65
Melanocyte - light, donor2	11351-117H1	1078.30	19.79	13.65	1.36	0.68
Melanocyte - light, donor3	11423-118G1	633.94	10.41	3.47	0.87	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	1114.87	13.33	4.17	1.15	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	886.16	31.20	8.07	1.34	4.30
Melanocyte, donor3 (MC+3)	12837-137B2	1025.08	9.37	8.04	1.07	2.68
Meningeal Cells, donor1	11493-119E8	565.96	8.81	1.12	0.25	0.62
Meningeal Cells, donor2	11573-120E7	363.12	7.04	0.88	0.00	0.88
Meningeal Cells, donor3	11654-122E7	265.29	6.52	1.87	0.33	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	599.40	21.39	4.85	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	471.36	13.28	4.93	1.21	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	855.52	7.88	1.31	3.94	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	609.60	6.54	5.23	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	589.15	12.92	5.02	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	837.33	8.89	4.45	0.64	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	617.75	12.06	6.03	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	600.80	13.62	4.61	0.00	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	553.06	13.88	5.11	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	548.54	9.41	6.55	0.61	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	810.82	19.11	2.49	0.14	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	734.16	15.98	2.97	1.49	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	374.86	6.05	1.58	0.66	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	921.08	14.84	1.48	1.48	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	390.04	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	398.33	12.81	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	568.88	12.41	3.90	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	439.69	6.57	1.25	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	333.09	8.71	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	406.25	7.16	5.57	1.06	1.33
Mesothelial Cells, donor2	12156-128G5	578.04	9.51	11.51	1.00	1.50
Mesothelial Cells, donor3	11402-118D7	255.17	4.99	2.75	0.87	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	1808.08	9.45	18.90	1.35	12.15
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	1100.11	11.82	22.66	0.74	6.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	934.61	13.84	30.92	0.29	4.42
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	988.72	0.00	24.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	923.02	12.71	13.64	0.62	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	741.16	10.16	23.23	0.62	5.81
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	694.81	2.32	6.95	4.63	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	1072.37	15.27	23.77	0.75	6.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	954.23	13.03	26.53	1.40	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	817.58	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	985.60	11.38	17.68	0.41	4.67
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	849.34	9.50	26.93	1.19	3.17
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	778.18	0.00	8.55	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1035.38	11.50	12.39	0.00	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	819.52	13.30	34.57	1.52	4.56
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	950.09	1.32	10.53	0.00	7.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	819.19	10.19	15.28	1.06	3.82
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	732.06	2.76	14.73	0.00	7.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	767.49	8.05	10.73	0.60	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	794.75	6.71	13.41	1.68	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	712.94	0.00	0.00	0.00	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	829.99	11.04	17.31	0.50	3.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	679.25	8.32	19.96	0.71	4.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1118.48	4.42	11.06	0.55	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	766.49	11.28	14.97	0.46	4.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	726.30	8.41	26.29	0.21	3.37
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	825.91	9.17	15.69	0.00	4.08
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	845.71	12.87	12.01	0.21	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	777.57	8.45	23.12	1.11	5.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	629.43	10.32	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	668.66	10.07	14.67	0.88	3.50
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	746.75	6.59	11.66	1.01	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	747.31	1.66	6.63	0.00	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	854.51	8.70	11.69	0.54	3.53
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	723.15	7.35	18.82	0.59	4.12
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	632.39	3.27	10.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	900.08	14.90	19.70	0.00	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	660.78	11.21	20.81	0.40	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	796.68	2.74	8.23	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	896.03	14.52	18.02	1.00	3.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	700.63	26.95	53.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	668.63	4.08	16.31	0.00	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	876.72	12.70	18.83	0.00	6.57
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	986.67	6.62	13.24	0.00	7.73
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	1002.85	4.48	12.17	0.64	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	832.76	8.43	16.61	1.24	4.96
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	798.89	5.57	9.05	0.00	6.26
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	1129.24	8.84	15.47	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	864.95	9.91	11.28	1.03	5.47
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1034.96	6.13	10.94	0.44	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	850.10	4.62	9.59	0.00	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	864.66	18.52	18.80	0.56	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1153.78	8.31	17.87	0.83	3.74
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	969.11	4.08	6.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	769.85	8.75	12.97	0.00	3.92
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	929.53	13.36	23.37	0.00	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	1025.07	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	915.24	6.46	9.24	0.00	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	1094.98	10.24	14.80	0.00	3.41
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	954.00	8.29	9.67	0.41	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	696.07	10.37	13.73	1.04	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1188.69	9.87	15.87	0.43	6.01
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1045.53	3.81	5.08	0.64	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	739.02	10.41	9.87	0.53	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	1261.37	13.17	16.16	0.00	2.39
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	839.90	6.07	5.93	0.42	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	777.49	13.38	13.70	0.64	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	1250.05	12.38	14.15	0.00	4.64
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1113.71	7.20	8.72	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	788.96	13.64	10.80	0.28	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1165.60	17.70	18.93	0.25	3.93
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	978.16	5.87	4.56	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	747.71	8.23	9.11	0.29	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	1265.75	12.97	21.05	0.29	4.04
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1317.21	5.36	8.66	0.00	2.47
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	829.62	4.17	9.83	0.60	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	1111.23	7.53	7.53	3.77	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1431.15	12.48	19.60	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1168.40	7.56	6.57	0.66	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1009.87	2.10	13.68	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1264.21	14.23	9.69	0.20	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1603.74	10.24	21.42	0.00	3.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1237.37	11.64	9.39	0.38	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1110.12	10.92	22.11	0.27	5.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	972.33	5.66	5.32	0.57	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	1186.86	6.63	11.79	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1010.60	3.66	5.86	0.37	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	942.69	3.11	4.67	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	956.64	5.34	5.34	1.07	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	1286.68	7.73	15.46	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1410.89	5.05	3.03	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	761.06	5.48	13.07	0.84	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	810.36	8.17	14.98	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2086.04	23.52	17.80	0.64	5.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1897.45	13.77	8.91	4.05	2.43
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	457.66	4.53	10.57	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	348.32	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	574.19	6.52	16.31	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	589.31	23.76	19.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	626.70	7.32	4.96	1.08	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	345.97	2.61	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	311.05	5.34	4.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	396.92	2.09	1.25	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1126.40	11.03	3.61	0.38	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	746.86	19.15	6.38	0.00	6.38
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	267.90	4.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	962.92	20.21	20.21	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	302.18	7.53	2.09	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	589.93	7.90	2.79	0.46	1.63
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	301.84	5.13	1.08	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	637.86	9.67	2.31	0.00	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1480.92	77.94	33.40	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	364.82	4.96	3.97	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	804.97	12.18	4.06	1.08	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	403.49	8.84	2.04	0.45	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	357.47	6.37	1.96	0.65	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	748.89	9.66	4.56	0.55	2.19
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	380.32	7.96	2.65	0.00	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	233.52	6.60	1.20	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	803.71	15.75	5.58	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	357.45	8.13	2.60	0.33	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	698.47	8.82	2.47	0.18	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	287.62	4.92	1.41	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	372.36	6.90	1.38	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	387.22	5.14	0.96	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	1124.68	20.69	8.62	1.03	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1284.45	7.59	17.70	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	666.13	7.80	1.56	0.45	2.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	374.70	6.77	1.69	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	484.91	6.88	1.42	0.24	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	342.11	5.58	1.72	0.43	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	767.36	18.06	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	418.86	5.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	412.99	2.25	0.45	0.00	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	225.78	4.36	0.79	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	245.16	3.71	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	642.85	10.22	2.27	0.00	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	211.17	4.24	0.65	0.33	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	281.08	4.79	0.87	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	455.45	4.98	1.36	0.90	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	204.60	2.65	0.88	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	294.53	5.98	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	320.44	2.98	2.98	0.99	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	183.37	2.30	0.38	0.38	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	1092.43	19.05	6.35	1.21	2.72
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	400.27	3.09	2.43	0.22	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	159.93	0.68	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	1067.89	10.22	30.66	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	418.85	2.44	0.61	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	219.06	4.41	0.63	1.57	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	324.44	6.96	1.82	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	192.25	2.37	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	649.58	5.67	3.40	0.00	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	1421.27	15.17	20.23	0.00	5.06
Myoblast, donor1	11241-116D8	662.76	19.38	14.41	1.24	3.23
Myoblast, donor2	11322-117D8	823.73	16.69	11.12	1.15	1.92
Myoblast, donor3	11398-118D3	1108.53	22.53	10.26	1.51	3.53
NK T cell leukemia cell line:KHYG-1	10777-110G3	153.67	1.17	0.00	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	88.26	1.54	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	66.64	0.60	0.30	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	80.80	0.00	0.37	0.74	0.37
Neural stem cells, donor1	11275-116H6	277.65	5.81	1.09	2.54	2.18
Neural stem cells, donor2	11352-117H2	175.23	3.85	1.93	7.70	1.93
Neurons, donor1	11494-119E9	368.68	11.38	0.00	5.69	2.28
Neurons, donor2	11574-120E8	236.02	6.16	0.66	6.83	0.44
Neurons, donor3	11655-122E8	322.29	8.22	0.82	2.47	0.00
Neutrophils, donor1	11233-116C9	232.00	0.93	0.00	2.78	1.86
Neutrophils, donor2	11314-117C9	237.71	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	302.37	0.61	0.00	3.67	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	420.56	12.23	1.54	0.36	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	476.68	6.51	2.28	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	745.25	16.45	2.81	0.20	1.80
Olfactory epithelial cells, donor1	11933-125I7	290.45	2.75	1.10	1.38	0.55
Olfactory epithelial cells, donor2	11934-125I8	405.72	8.11	1.74	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	327.35	2.84	1.48	2.16	0.57
Olfactory epithelial cells, donor4	11936-126A1	461.18	4.38	1.27	1.07	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	389.98	5.42	3.61	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	668.92	16.59	4.89	1.28	2.77
Osteoblast - differentiated, donor2	11353-117H3	765.89	28.58	9.14	1.14	5.72
Osteoblast - differentiated, donor3	11425-118G3	880.17	19.24	7.45	9.31	6.21
Osteoblast, donor1	11277-116H8	793.28	21.11	5.86	3.71	1.17
Osteoblast, donor2	11354-117H4	530.25	4.21	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	917.09	11.55	6.40	1.42	1.42
Pancreatic stromal cells, donor1	11249-116E7	602.87	8.76	4.46	1.43	0.93
Pericytes, donor1	11491-119E6	1055.58	17.02	2.00	0.22	2.11
Pericytes, donor2	11571-120E5	1012.31	19.24	3.62	0.00	2.26
Pericytes, donor3	11652-122E5	534.87	14.24	6.10	0.81	0.81
Perineurial Cells, donor1	11499-119F5	495.03	5.54	2.49	0.11	0.68
Perineurial Cells, donor2	11579-120F4	386.45	7.73	1.75	1.01	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	91.48	0.96	0.32	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	88.40	0.98	0.00	1.96	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	75.58	0.52	0.13	0.91	0.13
Placental Epithelial Cells, donor1	11278-116H9	289.87	3.83	0.00	8.61	1.67
Placental Epithelial Cells, donor2	11355-117H5	440.23	5.54	0.00	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	280.55	6.87	0.59	3.93	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	428.16	3.16	1.58	1.90	0.32
Preadipocyte - breast, donor1	11467-119B9	347.79	4.88	2.81	1.88	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	311.05	3.26	0.78	0.78	0.26
Preadipocyte - breast, donor2	11328-117E5	550.26	5.63	2.70	5.18	1.13
Preadipocyte - omental, donor1	11468-119C1	657.57	8.95	4.58	3.73	1.28
Preadipocyte - omental, donor2	11329-117E6	500.63	2.18	1.75	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	578.15	6.30	4.30	2.58	1.00
Preadipocyte - perirenal, donor1	11469-119C2	1142.73	11.81	4.92	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	578.61	14.13	8.29	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	530.70	8.32	4.96	0.89	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	846.48	11.58	7.66	1.02	3.41
Preadipocyte - visceral, donor1	11280-116I2	619.62	11.55	5.87	1.40	1.40
Preadipocyte - visceral, donor2	11357-117H7	525.53	7.82	5.06	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	653.80	11.18	6.37	0.84	1.67
Prostate Epithelial Cells (polarized), donor1	11253-116F2	217.68	5.43	1.51	2.72	1.66
Prostate Epithelial Cells, donor2	11331-117E8	203.80	2.71	2.71	1.62	0.14
Prostate Epithelial Cells, donor3	11404-118D9	171.77	3.00	1.71	6.67	0.37
Prostate Stromal Cells, donor1	11254-116F3	499.11	9.57	5.13	2.28	1.37
Prostate Stromal Cells, donor2	11332-117E9	644.22	10.04	6.99	0.36	1.43
Prostate Stromal Cells, donor3	11405-118E1	628.99	6.88	5.21	1.36	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	357.68	6.20	4.01	1.46	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	217.71	4.23	1.94	0.62	0.07
Renal Epithelial Cells, donor1	11517-119H5	478.83	7.10	5.07	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	367.75	7.82	5.69	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	267.84	4.34	1.59	0.53	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	473.19	6.81	2.04	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	407.93	3.37	1.08	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	266.64	3.55	0.67	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	407.25	4.66	0.67	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	484.85	9.24	2.86	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	367.41	6.27	3.76	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	419.17	9.99	2.22	0.28	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	402.63	6.71	1.34	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	317.53	5.90	1.27	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	366.60	7.14	2.70	1.16	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	468.52	20.22	3.89	0.78	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	343.08	11.37	1.71	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	429.14	13.38	5.15	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	278.01	11.04	1.76	0.50	1.76
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	398.77	4.01	0.94	2.00	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	177.79	2.68	0.00	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	105.67	7.15	2.20	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	130.51	4.64	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	326.36	5.72	0.52	0.91	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	213.31	3.97	0.60	1.09	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	271.04	4.68	1.23	1.56	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	305.27	4.47	1.49	1.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	223.30	3.50	0.82	1.28	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	238.76	4.62	1.16	3.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	234.25	3.15	0.68	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	214.05	3.18	0.76	1.36	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	290.29	6.27	1.43	3.58	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	233.12	4.16	0.43	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	228.26	3.43	0.75	1.72	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	242.51	2.88	0.22	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	205.71	3.06	0.19	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	227.97	3.54	0.93	1.77	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	197.87	3.57	1.13	3.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	324.60	3.05	0.40	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	220.77	2.92	0.88	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	234.50	4.39	1.34	3.63	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	284.82	2.88	0.32	0.75	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	223.40	4.48	0.28	1.96	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	240.62	3.76	0.85	1.88	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	268.21	2.37	0.36	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	199.77	3.56	1.10	2.33	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	277.37	4.57	1.21	3.22	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	194.59	2.83	0.24	2.36	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	210.12	2.98	0.60	0.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	261.44	5.38	1.17	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	221.46	2.49	0.21	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	237.14	4.42	0.44	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	243.14	3.55	0.84	2.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	253.83	4.04	0.67	1.62	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	244.54	2.04	0.85	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	236.56	2.51	0.19	0.96	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	195.66	4.47	0.52	1.38	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	243.34	3.98	0.82	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	227.05	4.60	0.82	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	235.54	3.07	0.00	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	266.47	4.73	1.04	1.78	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	214.04	3.73	0.00	1.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	346.08	5.25	0.41	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	299.53	5.95	0.95	1.90	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	303.72	4.43	0.81	1.01	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	332.81	3.48	0.66	0.75	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	307.44	4.89	2.45	3.49	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	315.81	2.42	1.51	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	329.59	4.53	0.86	1.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	209.60	4.22	0.73	2.77	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	403.39	8.52	1.83	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	328.22	4.52	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	368.01	6.33	1.36	1.58	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	277.07	3.89	0.00	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	410.90	9.68	0.12	1.53	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	291.35	6.62	0.85	2.99	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	191.11	4.21	0.60	2.40	0.60
Schwann Cells, donor1	11498-119F4	554.81	10.53	0.94	0.38	0.19
Schwann Cells, donor2	11578-120F3	268.79	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	384.49	5.48	0.66	0.22	0.22
Sebocyte, donor1	11220-116B5	223.49	1.64	0.55	2.74	0.00
Sebocyte, donor2	11301-117B5	107.08	1.38	0.92	1.38	0.00
Sebocyte, donor3	11378-118B1	322.98	5.15	2.27	3.30	0.41
Sertoli Cells, donor1	11255-116F4	644.42	4.97	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	398.24	0.00	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	419.83	15.48	2.55	3.08	1.14
Skeletal Muscle Cells, donor2	11358-117H8	524.78	20.24	5.06	3.61	2.17
Skeletal Muscle Cells, donor3	11430-118G8	727.35	15.05	5.02	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	478.35	10.53	4.71	0.00	1.26
Skeletal Muscle Cells, donor5	11455-119A6	432.70	8.18	3.42	0.00	2.08
Skeletal Muscle Cells, donor6	11459-119B1	489.56	7.85	2.92	0.15	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	444.80	13.73	3.15	0.38	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	470.02	8.13	2.28	0.14	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	472.54	5.65	3.87	0.50	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	321.51	12.13	2.61	1.94	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	586.97	10.13	5.79	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	676.30	18.03	4.68	0.83	3.03
Skin - palm, donor1	10286-104F7	131.62	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	151.94	1.59	0.58	0.29	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	73.61	0.82	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	85.04	1.43	0.26	0.91	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	261.33	5.14	1.95	4.45	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	236.87	4.50	1.55	0.70	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	254.58	5.92	1.48	1.27	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	230.02	2.47	2.40	3.45	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	172.19	3.70	3.39	1.23	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2652.41	29.13	14.67	0.67	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	872.92	11.76	10.58	2.35	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	407.07	16.57	1.99	1.99	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	772.20	12.60	11.81	2.36	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	983.48	10.82	10.82	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	280.21	8.01	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	493.32	10.51	5.32	3.46	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	639.03	16.85	4.88	1.77	3.10
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	872.53	13.06	6.66	2.69	0.90
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	484.80	11.72	5.86	0.33	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	683.09	11.22	4.43	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	529.88	6.83	9.68	0.14	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	882.67	12.04	7.32	0.33	2.28
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	539.46	7.31	2.13	0.61	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	748.85	10.36	4.55	4.04	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	244.83	30.60	6.12	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	555.51	13.83	6.20	2.38	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	472.51	7.52	5.31	0.29	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	500.21	7.75	4.95	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	529.41	7.03	5.88	0.73	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	737.20	12.22	8.51	2.47	1.08
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	680.14	14.01	12.93	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	639.85	8.07	5.38	2.39	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	574.57	10.92	3.76	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	310.74	5.10	1.26	0.31	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	456.71	7.35	7.45	2.01	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	734.77	17.75	8.65	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	765.03	21.74	4.83	0.60	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	370.90	9.27	3.44	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	667.13	11.72	3.46	0.67	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	500.63	9.52	7.64	2.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	867.02	10.40	5.07	1.78	2.54
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	741.95	17.34	7.69	1.96	2.41
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	703.66	18.00	6.00	2.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	511.72	33.60	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	695.75	10.70	5.12	2.33	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	598.79	14.14	8.58	4.04	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	574.77	12.54	8.46	2.19	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	638.08	11.50	7.37	0.00	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	446.02	7.50	3.08	0.83	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	568.53	10.28	3.27	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	528.32	10.94	6.48	2.45	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	562.43	7.90	8.16	1.78	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	581.77	13.73	3.95	1.69	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	411.41	10.90	2.79	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	527.28	8.63	2.26	1.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	625.70	7.14	7.62	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	561.50	8.32	8.56	3.67	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	789.01	13.48	4.42	0.22	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	763.92	10.24	7.31	0.88	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	716.41	4.86	0.97	2.14	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	676.21	12.96	5.55	0.26	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	572.80	13.39	4.84	1.86	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	601.53	10.06	9.70	1.08	2.87
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	469.00	10.50	11.36	0.57	3.41
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	406.08	3.54	1.97	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	635.64	10.41	2.79	2.03	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	611.36	13.18	4.39	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	710.19	10.45	4.60	1.67	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	638.95	1.83	3.21	1.38	0.92
Synoviocyte, donor1	11291-117A4	386.46	5.55	1.35	1.01	0.84
Synoviocyte, donor2	11368-117I9	663.62	13.58	5.87	3.35	1.34
Synoviocyte, donor3	11440-118H9	633.81	9.38	2.46	1.12	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	644.63	14.65	3.93	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	487.58	13.87	3.96	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	573.54	10.65	2.78	1.39	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	164.80	5.45	1.15	2.15	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	220.34	6.19	3.87	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	240.52	2.86	1.72	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	395.40	4.55	0.74	1.11	0.49
Urethra, donor2	10319-105A4	246.38	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	277.62	4.25	1.33	0.53	0.00
Urothelial Cells, donor2	11600-120H7	191.87	1.20	0.80	0.80	0.40
Urothelial Cells, donor3	11681-122H7	221.18	2.06	1.38	0.69	0.00
Urothelial cells, donor0	11216-116B1	275.05	1.34	0.67	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	224.23	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	245.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	104.05	0.00	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	103.65	1.03	0.00	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	95.87	1.74	0.00	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	208.25	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	208.34	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	97.68	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	230.56	5.06	1.48	1.48	1.23
Wilms' tumor cell line:HFWT	10597-108E3	137.29	7.04	0.00	6.16	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	87.15	1.96	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	192.19	4.13	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	85.16	2.29	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.24	1.39	0.00	1.63	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	93.66	0.36	0.00	1.07	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	30.20	1.36	0.54	3.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	34.85	1.12	0.00	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	162.42	9.09	1.48	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	69.14	4.36	0.54	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	157.75	3.08	1.32	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	178.86	9.39	2.04	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	108.72	1.55	0.78	1.16	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.80	1.29	0.92	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	136.52	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	67.16	1.63	0.70	0.46	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	57.22	0.00	0.52	0.78	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	86.21	3.51	0.88	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	138.50	6.04	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	137.36	8.64	2.06	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	239.11	2.76	0.92	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	225.30	9.39	2.99	2.13	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	252.34	11.53	1.52	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	225.30	10.83	2.89	1.68	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	81.08	1.56	2.45	1.78	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	132.42	2.33	1.33	1.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	133.79	0.00	1.86	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	216.20	14.31	4.14	1.88	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	113.39	17.01	1.31	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	221.19	9.37	1.87	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	176.39	4.00	0.71	2.59	0.24
adipose tissue, adult, pool1	10010-101C1	402.38	3.26	0.93	1.55	0.62
adipose, donor1	10184-103D4	358.30	16.42	1.76	5.28	2.93
adipose, donor2	10185-103D5	125.31	13.79	1.22	0.81	0.81
adipose, donor3	10186-103D6	156.29	18.52	0.54	2.45	0.82
adipose, donor4	10187-103D7	226.22	5.20	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	78.44	9.15	3.00	3.00	0.00
adrenal gland, adult, pool1	10081-102A9	236.45	14.55	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	86.98	0.53	0.13	3.07	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	397.32	3.93	1.79	2.50	0.36
amniotic membrane cells, donor1	12235-129G3	297.69	10.43	0.46	4.17	0.23
amniotic membrane cells, donor2	12236-129G4	405.39	3.38	0.68	4.40	0.68
amniotic membrane cells, donor3	12237-129G5	282.23	3.83	0.59	3.54	0.29
amygdala - adult, donor10196	10167-103B5	84.19	3.56	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	149.44	3.04	0.20	8.52	0.20
amygdala, newborn, donor10223	10360-105E9	104.90	2.26	0.00	4.20	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	270.07	12.61	2.80	1.27	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	172.53	1.76	0.88	1.10	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	94.53	11.02	0.33	0.33	0.00
aorta, adult, pool1	10052-101G7	360.49	5.30	0.78	1.77	0.39
appendix, adult	10189-103D9	182.42	3.88	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	201.55	13.07	2.75	3.10	0.00
artery, adult	10190-103E1	211.96	4.08	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	315.38	5.65	1.59	0.87	1.45
b cell line:RPMI1788	10427-106D4	40.60	0.45	0.30	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	575.98	4.44	4.44	2.50	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	174.45	5.16	2.88	0.50	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	191.31	10.21	1.17	3.51	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	69.35	3.36	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	341.24	4.13	0.33	1.74	0.11
blood, adult, pool1	10053-101G8	70.87	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	890.60	6.85	1.71	3.43	0.00
bone marrow, adult	10192-103E3	467.65	21.59	2.02	2.02	1.35
brain, adult, donor1	10084-102B3	105.58	5.13	1.03	2.05	0.00
brain, adult, pool1	10012-101C3	118.15	4.90	0.33	1.78	0.00
brain, fetal, pool1	10085-102B4	98.84	5.34	0.00	16.03	2.67
breast carcinoma cell line:MCF7	10482-107A5	191.94	8.59	1.32	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	161.52	17.10	0.37	5.99	0.00
breast, adult, donor1	10080-102A8	295.47	3.16	1.26	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	129.71	20.33	3.43	1.40	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	95.55	9.59	1.55	1.24	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	203.51	9.21	5.99	2.07	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	75.53	5.08	0.48	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	69.58	2.82	0.47	3.29	0.00
carcinoid cell line:NCI-H727	10735-110B6	293.91	14.66	3.28	2.73	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	106.16	1.90	0.32	1.90	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	171.95	15.97	1.60	2.13	1.33
caudate nucleus - adult, donor10196	10177-103C6	110.53	3.45	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	122.32	3.35	0.17	4.18	0.00
caudate nucleus, adult, donor10258	10379-105H1	93.99	3.06	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	123.42	3.30	0.00	3.66	0.00
cerebellum - adult, donor10196	10173-103C2	58.27	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	84.76	2.78	0.21	3.63	0.00
cerebellum, adult, pool1	10083-102B2	66.23	2.41	0.00	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	68.08	2.49	0.00	4.15	1.66
cerebral meninges, adult	10188-103D8	141.45	5.55	0.25	6.30	0.25
cerebrospinal fluid, donor2	10294-104G6	75.28	2.19	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	68.73	11.50	0.86	5.46	0.14
cervical cancer cell line:ME-180	10553-107I4	131.25	6.13	0.66	3.31	0.33
cervix, adult, pool1	10013-101C4	377.65	6.93	0.52	1.26	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	675.10	7.94	3.62	0.98	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	250.80	7.84	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	223.08	1.86	0.75	5.59	0.99
choriocarcinoma cell line:SCH	10785-110H2	134.67	2.34	0.62	5.05	1.85
choriocarcinoma cell line:T3M-3	10618-108G6	122.62	1.19	1.19	2.61	2.61
chorionic membrane cells, donor1	12238-129G6	468.12	13.68	4.56	3.70	1.42
chorionic membrane cells, donor2	12239-129G7	892.89	9.64	9.25	2.09	1.19
chorionic membrane cells, donor3	12240-129G8	522.01	17.58	3.30	2.20	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	24.24	0.00	0.00	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	220.34	4.23	0.38	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	194.08	4.01	2.11	0.21	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	117.36	0.77	0.77	1.54	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	123.60	0.73	0.48	1.45	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	108.12	0.41	0.61	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	167.25	1.47	1.18	1.47	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	84.70	3.91	0.26	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	160.92	14.40	5.49	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	253.49	10.76	0.87	0.87	0.52
colon carcinoma cell line:CACO-2	10513-107D9	415.69	3.11	3.29	1.65	3.48
colon carcinoma cell line:COLO-320	10420-106C6	114.02	1.14	0.38	5.32	0.00
colon, adult, donor1	10082-102B1	295.13	0.00	3.57	2.38	0.00
colon, adult, pool1	10014-101C5	361.91	5.76	0.59	1.88	0.82
colon, fetal, donor1	10070-101I7	221.86	3.09	1.24	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	151.26	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	250.37	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	28.90	0.42	0.00	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.01	0.45	0.15	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	53.58	0.56	0.28	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	174.47	6.85	0.22	3.65	0.22
cruciate ligament, donor2	10295-104G7	257.73	1.62	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	301.76	3.21	0.00	1.61	0.00
diencephalon, adult	10193-103E4	101.04	3.84	0.00	3.12	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.88	0.23	0.00	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	120.01	13.08	0.77	1.80	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	153.34	4.81	1.20	0.48	0.24
ductus deferens, adult	10196-103E7	275.08	7.97	1.00	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	253.48	8.64	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	306.03	7.36	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	436.80	10.65	0.41	1.65	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	66.40	1.55	0.22	15.32	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	121.51	1.58	0.00	3.58	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	223.83	8.02	5.55	3.08	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	176.48	4.54	1.82	4.54	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	244.84	8.64	3.40	3.09	0.62
embryonic pancreas cell line:2C6	10603-108E9	329.68	5.25	3.94	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	406.26	34.19	4.69	2.01	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	238.87	20.84	6.89	11.06	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	128.17	5.79	1.93	2.09	0.16
epidermoid carcinoma cell line:A431	10426-106D3	83.70	6.67	0.44	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	164.32	3.74	0.66	1.54	0.11
epididymis, adult	10197-103E8	375.50	10.05	0.63	2.30	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	218.21	6.74	0.53	1.06	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	119.94	1.18	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	167.48	5.11	3.93	2.49	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	144.38	3.84	2.36	4.53	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	176.22	5.49	2.91	2.24	1.12
esophagus, adult, pool1	10015-101C6	241.66	2.76	0.53	1.17	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	252.60	22.67	1.00	5.39	0.38
eye - muscle inferior rectus, donor1	10272-104E2	144.87	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	119.94	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	162.22	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	198.34	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	107.85	2.91	1.46	2.91	0.00
eye, fetal, donor1	10054-101G9	320.08	11.44	0.76	2.03	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	103.73	4.49	0.64	0.64	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	200.86	5.70	2.61	1.42	0.24
frontal lobe, adult, pool1	10040-101F4	88.66	3.38	0.38	10.60	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	181.95	7.81	1.20	3.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	308.05	10.52	1.28	0.64	0.09
gall bladder, adult	10198-103E9	373.50	7.73	1.21	1.69	0.72
gamma delta positive T cells, donor1	11937-126A2	108.44	2.15	0.54	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	154.25	1.87	0.37	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	242.27	2.53	2.11	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	167.50	10.25	2.71	4.45	0.97
gastric cancer cell line:AZ521	10549-107H9	133.46	3.61	2.62	5.41	0.33
gastric cancer cell line:GSS	10560-108A2	140.03	1.83	0.00	2.75	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	369.19	7.54	0.23	0.46	0.23
giant cell carcinoma cell line:LU65	10487-107B1	75.38	0.80	0.23	4.36	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	202.94	5.60	1.54	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	150.40	18.21	2.24	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	243.61	5.38	2.11	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	336.49	6.04	2.25	0.42	0.56
glioblastoma cell line:T98G	10485-107A8	175.38	5.96	1.32	0.88	0.22
glioma cell line:GI-1	10413-106B8	193.88	5.27	1.46	1.46	0.59
globus pallidus - adult, donor10196	10175-103C4	158.17	3.64	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	212.36	2.69	0.24	6.59	0.00
globus pallidus, adult, donor10258	10367-105F7	124.60	6.85	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	123.64	2.13	0.00	3.20	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	264.29	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	207.64	32.79	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	339.73	15.68	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	460.47	2.88	1.60	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	232.77	1.38	0.46	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	179.70	2.74	0.46	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	252.48	1.93	0.00	1.93	1.29
hIPS, biol_rep1	14380-156B6	209.84	0.00	1.44	4.31	0.00
hIPS, biol_rep2	14381-156B7	268.17	2.06	0.69	2.06	1.37
hIPS, biol_rep3	14382-156B8	144.55	3.31	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	58.33	0.86	0.86	0.29	0.00
heart - mitral valve, adult	10205-103F7	313.32	6.88	0.30	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	243.96	2.61	0.00	1.05	0.26
heart - tricuspid valve, adult	10207-103F9	330.56	1.67	1.67	2.50	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	297.11	2.24	1.43	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	406.67	2.55	1.28	0.85	0.00
heart, adult, pool1	10016-101C7	484.79	1.61	0.46	2.30	0.00
heart, fetal, pool1	10046-101G1	366.26	4.11	0.62	0.72	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	611.19	4.32	4.01	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	104.65	0.00	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	140.33	2.21	1.88	2.32	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	143.95	2.55	0.97	3.16	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	142.69	2.02	1.41	3.44	0.40
hepatoma cell line:Li-7	10484-107A7	667.63	6.90	2.34	3.56	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	69.65	6.53	0.70	0.40	0.00
hippocampus - adult, donor10196	10169-103B7	120.18	0.00	0.00	4.73	0.00
hippocampus, adult, donor10252	10153-102I9	163.69	3.88	0.00	7.76	0.00
hippocampus, adult, donor10258	10374-105G5	82.66	2.99	0.00	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	78.60	1.76	0.00	6.34	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	284.42	6.71	1.83	5.49	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	158.07	2.36	0.59	3.93	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	156.40	3.30	0.51	2.29	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	151.68	4.51	0.56	1.13	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	145.11	3.36	1.03	0.77	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	132.48	4.18	0.38	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	116.49	9.34	0.58	4.67	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	103.62	8.19	0.43	2.80	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.42	6.26	1.67	3.75	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	166.70	19.42	0.71	7.34	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	124.88	12.05	0.32	3.86	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	162.27	20.20	0.67	3.37	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	124.87	3.29	0.31	2.19	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	132.65	1.97	0.49	1.47	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	143.13	3.49	0.87	7.85	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	139.94	6.87	1.15	0.76	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	129.08	2.62	0.00	3.05	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	188.91	8.00	1.00	2.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	117.37	16.58	0.75	2.64	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	116.86	22.74	0.00	2.73	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	127.49	15.98	0.63	2.19	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	131.29	34.95	0.49	4.41	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	117.28	33.10	0.29	3.48	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	131.23	34.97	0.30	3.29	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	177.72	2.77	0.00	4.06	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	187.15	3.14	0.86	2.85	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	285.82	3.67	0.41	6.12	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	169.00	5.99	0.35	1.41	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	157.74	4.43	1.27	1.58	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	161.60	5.14	0.91	2.42	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	134.97	16.55	1.03	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	118.22	15.28	0.00	3.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	110.05	7.44	1.03	1.80	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	171.80	17.64	1.28	3.58	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	142.36	34.08	0.00	4.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	175.42	20.16	0.00	3.02	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	157.70	3.86	0.97	2.90	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	166.68	4.90	1.34	5.79	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	200.49	3.41	0.98	3.90	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	139.97	2.75	0.31	1.83	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	416.42	26.03	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	189.30	4.96	1.32	2.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	107.82	6.02	1.09	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	84.68	9.05	0.36	3.98	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	96.09	7.12	0.36	2.85	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	113.37	10.74	0.00	9.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	154.52	16.39	0.27	5.01	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	132.81	21.82	0.27	5.12	0.27
immature langerhans cells, donor1	11904-125F5	374.12	5.33	3.15	3.15	0.97
immature langerhans cells, donor2	11905-125F6	185.36	0.79	1.58	3.96	0.79
insula, adult, pool1	10039-101F3	106.37	3.79	0.95	9.46	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	106.97	3.90	1.63	1.30	0.00
kidney, adult, pool1	10017-101C8	405.32	6.01	1.10	2.40	0.30
kidney, fetal, pool1	10045-101F9	290.58	8.63	0.42	1.41	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	469.95	14.20	4.26	1.42	3.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	283.81	10.92	1.38	2.76	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	211.21	4.59	1.47	0.55	0.18
left atrium, adult, donor1	10079-102A7	524.15	2.18	0.54	1.09	0.00
left ventricle, adult, donor1	10078-102A6	303.39	0.51	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	121.48	3.56	0.00	1.09	0.55
leiomyoma cell line:10964C	10569-108B2	1178.70	37.00	20.84	0.00	4.31
leiomyoma cell line:15242A	10570-108B3	1024.46	26.09	26.09	2.17	4.89
leiomyoma cell line:15425	10571-108B4	922.46	18.45	16.03	1.94	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	755.57	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	315.76	4.18	4.18	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	280.74	2.95	2.24	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	703.57	13.12	4.37	2.03	0.31
liposarcoma cell line:SW 872	10726-110A6	300.94	6.34	1.10	1.46	0.37
liver, adult, pool1	10018-101C9	271.61	2.11	0.16	2.92	0.00
liver, fetal, pool1	10086-102B5	177.79	2.82	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	101.93	2.92	0.15	1.31	0.15
locus coeruleus, adult, donor10252	10165-103B3	187.32	2.95	0.18	6.27	0.18
locus coeruleus, adult, donor10258	10375-105G6	96.77	2.82	0.56	5.64	0.00
locus coeruleus, newborn, donor10223	10362-105F2	146.38	2.94	0.42	3.36	0.00
lung adenocarcinoma cell line:A549	10499-107C4	269.18	11.76	5.12	3.74	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	177.18	6.20	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	377.26	18.59	3.16	1.71	0.92
lung, adult, pool1	10019-101D1	502.99	6.14	2.01	1.54	0.00
lung, fetal, donor1	10068-101I5	394.15	9.13	0.29	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	313.88	5.04	1.37	0.46	0.00
lymph node, adult, donor1	10077-102A5	325.20	1.89	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	103.01	1.32	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	50.26	1.36	0.30	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	122.33	5.10	0.85	1.70	0.85
mature adipocyte, donor1	12231-129F8	820.49	5.77	0.89	3.11	2.22
mature adipocyte, donor2	12232-129F9	670.11	6.23	0.42	2.49	0.62
mature adipocyte, donor3	12233-129G1	604.04	10.19	1.42	7.11	0.71
mature adipocyte, donor4	12234-129G2	551.18	6.32	1.05	5.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	194.90	9.05	1.43	3.34	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	87.99	4.51	1.13	5.64	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	115.68	1.84	0.37	5.33	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	104.52	4.45	0.32	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	101.93	3.41	0.43	11.09	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	78.64	2.03	0.34	4.73	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	126.70	1.91	0.21	4.67	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	0.00	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	14.35	0.00	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	73.94	2.15	1.08	4.67	0.00
medulla oblongata - adult, donor10196	10174-103C3	260.89	8.44	1.95	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	187.78	2.94	0.31	3.56	0.00
medulla oblongata, adult, pool1	10038-101F2	148.15	4.57	0.24	3.18	0.16
medulla oblongata, newborn, donor10223	10361-105F1	165.61	3.82	1.04	2.08	0.00
medulloblastoma cell line:D283 Med	10838-111E1	70.19	6.42	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	160.91	4.77	0.86	0.49	0.00
melanoma cell line:COLO 679	10514-107E1	1048.34	59.80	12.51	4.02	3.02
melanoma cell line:G-361	10465-106H6	592.87	29.32	5.97	1.09	2.99
meningioma cell line:HKBMM	10691-109F7	305.91	12.12	2.71	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	87.23	3.52	0.88	5.29	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	47.96	4.93	0.26	3.37	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	819.34	14.42	9.82	1.53	3.22
mesenchymal precursor cell - adipose, donor2	11748-123G2	653.14	9.27	3.27	2.00	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	807.91	14.08	4.97	0.83	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1227.05	18.40	11.66	1.69	3.51
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	1467.37	18.29	13.29	0.77	4.62
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	958.52	22.90	13.88	0.00	9.72
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1112.71	10.98	10.81	2.92	3.78
mesenchymal precursor cell - cardiac, donor2	11753-123G7	1004.20	11.16	8.40	1.27	4.72
mesenchymal precursor cell - cardiac, donor3	11754-123G8	616.63	7.83	3.85	1.46	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	968.37	10.40	9.05	1.08	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	748.16	11.95	9.82	0.71	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	472.95	9.22	6.92	0.99	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	764.09	16.05	6.64	1.11	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	678.62	18.85	9.08	1.40	3.14
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1255.20	17.97	16.95	1.02	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	391.45	9.35	6.11	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	804.32	14.59	5.90	0.41	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	333.10	5.47	7.98	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	740.94	14.26	6.71	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	1044.57	10.91	8.07	0.90	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	651.67	11.90	7.35	1.14	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	829.83	5.15	6.26	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	388.89	5.72	8.30	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	695.52	22.31	3.37	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	566.27	8.68	5.94	2.74	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	458.11	8.19	2.56	1.28	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	455.19	7.59	3.93	1.31	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	435.02	10.17	2.46	1.54	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	441.29	8.24	2.12	1.65	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	461.65	9.82	4.40	1.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	421.27	5.89	2.75	0.39	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	375.34	7.41	3.71	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	627.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	559.24	8.94	5.19	2.60	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	477.43	9.15	2.45	2.45	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	483.35	7.21	2.16	1.92	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	521.40	7.33	2.20	0.73	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	432.33	5.03	1.01	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	425.75	9.01	2.46	2.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	436.00	9.45	3.01	0.86	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	442.97	16.41	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	408.03	10.33	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	441.71	6.17	5.20	1.62	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	490.33	5.82	4.36	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	489.37	9.06	2.13	1.60	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	435.05	8.18	3.27	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	389.89	9.33	3.11	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	373.57	12.59	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	394.41	8.94	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	491.02	4.77	4.77	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	419.82	7.71	0.59	1.78	2.96
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	528.81	4.87	2.44	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	595.15	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	454.77	6.97	2.53	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	382.84	6.21	1.38	2.41	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	367.51	12.90	6.45	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	351.28	7.98	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	492.48	6.89	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	486.52	9.37	3.67	4.48	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	490.97	13.51	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	417.97	7.07	0.59	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	422.36	4.99	0.94	2.81	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	409.02	4.01	0.00	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	520.38	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	508.46	5.14	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	583.07	2.75	4.13	2.07	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	531.42	7.42	0.99	1.48	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	447.48	6.73	1.12	1.12	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	514.58	8.27	3.18	3.18	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	735.44	5.64	1.61	2.42	6.04
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	789.37	13.08	6.54	6.54	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	737.43	3.80	2.53	0.00	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	626.91	2.43	3.03	5.46	11.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	781.78	9.04	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	560.10	6.59	0.00	3.29	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	497.45	4.56	0.79	2.78	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	441.96	4.54	0.00	2.27	3.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	506.26	7.13	3.06	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	512.20	8.51	3.09	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	424.29	1.18	0.94	6.14	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	152.90	2.55	0.46	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	179.49	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	531.12	2.57	1.64	0.92	0.31
mesothelioma cell line:Mero-25	10850-111F4	205.85	10.21	0.91	3.63	0.68
mesothelioma cell line:Mero-41	10851-111F5	235.43	8.31	2.44	0.24	0.49
mesothelioma cell line:Mero-48a	10852-111F6	200.17	7.09	2.88	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	239.42	6.57	0.26	0.53	1.05
mesothelioma cell line:Mero-83	10854-111F8	147.92	2.55	0.51	0.51	0.34
mesothelioma cell line:Mero-84	10855-111F9	236.34	3.79	1.77	0.76	0.76
mesothelioma cell line:Mero-95	10856-111G1	216.36	10.56	2.90	1.24	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	221.80	5.47	0.83	0.83	0.33
mesothelioma cell line:NCI-H226	10846-111E9	297.55	8.51	4.16	0.18	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	264.60	8.20	2.56	1.54	0.51
mesothelioma cell line:NCI-H28	10845-111E8	273.30	7.89	4.58	1.53	0.51
mesothelioma cell line:No36	10857-111G2	192.46	0.65	0.65	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	322.16	4.88	1.63	1.08	0.27
migratory langerhans cells, donor1	11901-125F2	146.63	0.38	0.00	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	153.38	0.24	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	138.92	0.54	0.18	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	342.15	1.31	0.98	1.63	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	364.95	6.15	3.39	0.42	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	211.93	8.29	3.92	1.15	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.46	0.76	0.19	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.22	4.07	0.74	2.03	0.00
myeloma cell line:PCM6	10474-106I6	178.30	3.76	0.40	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	205.45	5.58	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	860.07	3.33	3.33	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	215.38	3.57	0.78	3.79	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	232.76	4.19	0.59	5.96	0.29
nasal epithelial cells, donor2	12227-129F4	240.12	5.52	1.10	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	106.06	1.38	0.23	5.75	0.00
neuroblastoma cell line:NB-1	10539-107G8	347.23	4.12	0.00	2.25	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	120.63	6.75	2.95	10.33	0.00
neuroblastoma cell line:NH-12	10555-107I6	194.92	2.98	0.37	2.42	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	69.98	21.11	2.61	6.64	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	169.63	13.30	2.22	3.48	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	77.28	8.65	0.40	3.62	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	86.46	4.45	1.27	6.36	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	419.74	5.32	1.33	1.06	0.80
neutrophil PMN, donor1	12133-128D9	788.36	0.00	14.87	0.00	14.87
neutrophil PMN, donor2	12137-128E4	1062.45	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	1108.06	9.47	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	83.04	1.86	0.34	0.00	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	842.93	27.22	4.00	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	741.24	12.50	1.92	3.85	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	470.35	9.20	3.15	1.58	0.26
nucleus accumbens, adult, pool1	10037-101F1	102.64	4.03	0.84	6.75	0.00
occipital cortex - adult, donor10196	10172-103C1	90.66	0.00	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	148.94	0.81	0.81	4.03	0.27
occipital cortex, newborn, donor10223	10355-105E4	53.14	2.18	0.36	7.64	0.00
occipital lobe, adult, donor1	10076-102A4	81.34	4.46	0.26	4.46	0.00
occipital lobe, fetal, donor1	10073-102A1	57.07	7.72	0.43	6.44	0.00
occipital pole, adult, pool1	10036-101E9	88.62	3.15	0.32	5.68	0.00
olfactory region, adult	10195-103E6	92.66	3.06	0.38	3.25	0.19
optic nerve, donor1	10277-104E7	124.06	2.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	84.18	4.44	0.80	2.16	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	108.81	8.24	0.27	2.89	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	144.77	8.13	1.02	0.34	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	189.20	6.70	2.77	0.92	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	413.61	6.76	2.06	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	245.73	3.74	0.00	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	481.16	6.57	1.06	2.33	0.00
ovary, adult, pool1	10020-101D2	343.64	9.08	0.52	1.22	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	308.34	6.97	1.47	0.92	0.18
pancreas, adult, donor1	10049-101G4	573.79	49.85	2.82	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	134.46	0.28	1.12	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	199.31	3.41	0.34	1.53	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	248.70	10.60	1.49	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	86.58	3.20	0.18	9.52	0.00
parietal cortex, adult, donor10258	10373-105G4	63.12	2.94	0.00	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	95.93	3.76	0.00	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	99.48	1.14	0.00	5.70	0.00
parietal lobe, adult, pool1	10034-101E7	96.84	3.00	0.44	6.96	0.00
parietal lobe, fetal, donor1	10072-101I9	60.13	3.88	0.00	7.76	0.00
parietal lobe, newborn, donor10223	10356-105E5	81.13	1.87	1.12	7.10	0.75
parotid gland, adult	10199-103F1	322.52	10.48	0.00	5.55	0.00
penis, adult	10200-103F2	238.48	2.15	0.54	4.83	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	43.32	23.99	0.19	4.28	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	229.18	15.44	1.60	1.75	0.29
pineal gland - adult, donor10196	10179-103C8	254.14	38.06	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	254.06	38.49	2.37	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	235.15	46.40	1.25	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	322.76	14.17	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	311.67	11.99	0.52	9.38	0.00
pituitary gland, adult, donor10258	10378-105G9	220.47	27.24	0.85	2.55	0.00
placenta, adult, pool1	10021-101D3	628.89	7.74	2.90	0.97	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	60.39	0.40	0.00	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	662.09	13.38	2.18	0.78	0.31
pons, adult, pool1	10033-101E6	74.36	2.75	0.09	4.48	0.00
postcentral gyrus, adult, pool1	10032-101E5	86.91	3.75	0.52	7.58	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	447.56	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	418.61	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	528.11	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	203.64	12.24	2.48	2.62	0.44
prostate cancer cell line:PC-3	10439-106E7	429.80	12.34	6.53	3.27	0.18
prostate, adult, pool1	10022-101D4	324.22	4.08	0.27	2.27	0.18
putamen, adult, donor10196	10176-103C5	91.59	2.36	0.24	6.85	0.00
putamen, adult, donor10252	10152-102I8	174.50	5.88	1.96	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	77.59	1.09	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	79.01	3.87	0.00	1.93	0.00
putamen, newborn, donor10223	10365-105F5	95.21	3.00	0.00	7.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	143.14	6.11	1.75	0.87	0.29
rectum, fetal, donor1	10067-101I4	230.90	8.35	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	328.60	13.14	2.33	0.85	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	232.37	6.21	1.24	1.24	0.00
retina, adult, pool1	10030-101E3	470.66	21.37	0.99	2.88	0.60
retinoblastoma cell line:Y79	10475-106I7	76.38	4.42	0.26	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	149.01	4.30	0.86	2.09	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	418.71	4.78	1.41	2.53	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	469.87	6.06	2.27	2.27	0.00
salivary acinar cells, donor1	11771-123I7	208.15	4.21	1.29	0.97	0.16
salivary acinar cells, donor2	11772-123I8	212.31	5.37	0.69	1.65	0.00
salivary acinar cells, donor3	11773-123I9	207.88	2.65	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	474.72	24.02	0.00	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	223.09	13.91	3.63	3.96	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	334.55	15.75	5.52	3.53	0.94
seminal vesicle, adult	10201-103F3	295.22	16.40	1.59	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	213.29	7.04	0.73	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	643.42	6.04	2.26	1.51	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	274.97	4.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	453.20	2.55	0.54	3.22	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	247.03	5.75	3.32	2.32	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	426.04	8.13	6.71	1.29	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	129.10	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	342.66	0.96	0.48	0.96	0.24
skeletal muscle, fetal, donor1	10066-101I3	376.88	6.03	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	135.70	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	344.02	13.89	0.00	3.79	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	258.48	10.34	2.00	4.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	145.62	4.73	0.63	1.58	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	68.23	9.25	2.51	1.73	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	229.93	21.43	2.14	2.47	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	87.98	1.61	0.16	1.13	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	165.62	12.20	0.22	5.01	0.00
small intestine, adult, pool1	10024-101D6	346.15	2.87	0.60	1.67	0.00
small intestine, fetal, donor1	10064-101I1	435.87	15.72	1.47	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	383.14	15.90	2.05	3.59	0.00
smooth muscle, adult, pool1	10048-101G3	279.91	2.84	0.00	0.78	0.52
somatostatinoma cell line:QGP-1	10781-110G7	342.80	28.68	2.95	2.14	0.00
spinal cord - adult, donor10196	10181-103D1	136.96	5.74	0.23	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	209.36	2.37	0.39	3.55	0.00
spinal cord, adult, donor10258	10369-105F9	206.85	8.30	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	197.59	9.76	1.22	4.27	1.22
spinal cord, newborn, donor10223	10359-105E8	192.87	3.67	0.00	2.30	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	646.41	7.77	3.58	0.60	0.75
spleen, adult, pool1	10025-101D7	398.80	2.97	0.55	0.55	0.33
spleen, fetal, pool1	10044-101F8	255.61	2.54	0.24	0.87	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	41.40	0.52	0.31	0.31	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	151.90	7.78	0.19	2.66	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	177.87	1.05	0.35	2.80	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	227.52	1.17	1.17	2.74	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	185.16	4.39	0.56	3.38	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	117.34	8.47	2.12	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	146.81	0.85	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	531.85	13.88	3.20	3.20	0.00
submaxillary gland, adult	10202-103F4	222.18	6.27	1.14	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	651.29	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	198.57	3.12	0.00	5.40	0.00
substantia nigra, adult, donor10258	10371-105G2	154.14	4.66	0.00	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	149.09	2.83	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	143.52	10.55	2.52	3.44	0.46
temporal lobe, adult, pool1	10031-101E4	111.56	4.92	0.59	9.66	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	88.32	7.12	0.71	7.12	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	66.81	7.47	0.00	10.11	0.00
tenocyte, donor1	11763-123H8	1093.03	9.77	4.89	2.09	2.09
tenocyte, donor2	11765-123I1	983.52	6.10	3.05	4.58	1.14
tenocyte, donor3	11768-123I4	1067.15	16.68	12.23	0.37	5.19
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	106.23	3.57	0.68	1.02	2.21
teratocarcinoma cell line:NCR-G1	10798-110I6	279.32	6.01	0.62	2.16	1.08
teratocarcinoma cell line:PA-1	10807-111A6	160.71	1.70	0.62	2.32	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	190.04	1.14	1.52	1.40	10.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	138.79	1.89	0.76	2.65	9.08
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	137.96	1.64	0.98	0.65	6.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	73.93	0.98	0.65	0.98	7.49
testis, adult, pool1	10026-101D8	324.80	4.62	0.54	1.29	0.43
testis, adult, pool2	10096-102C6	186.75	7.67	0.90	1.35	0.00
thalamus - adult, donor10196	10168-103B6	138.00	3.31	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	150.81	1.41	0.16	2.19	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	70.82	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	76.25	2.80	0.00	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	80.54	4.60	0.00	5.75	0.00
throat, adult	10209-103G2	210.22	4.49	1.00	1.50	0.25
throat, fetal, donor1	10061-101H7	340.66	8.23	1.22	1.52	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	84.26	2.98	0.00	2.78	0.20
thymus, adult, pool1	10027-101D9	69.19	0.89	0.10	0.20	0.10
thymus, fetal, pool1	10043-101F7	104.84	1.04	0.21	1.14	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	398.08	3.72	0.93	1.33	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	179.36	3.35	0.98	0.42	0.42
thyroid, adult, pool1	10028-101E1	455.09	13.16	0.28	2.99	0.19
thyroid, fetal, donor1	10060-101H6	314.02	11.34	0.26	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	163.22	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	155.13	1.40	0.23	2.56	0.47
tongue, fetal, donor1	10059-101H5	346.80	5.52	0.00	0.79	0.79
tonsil, adult, pool1	10047-101G2	215.28	3.31	0.40	2.50	0.20
trachea, adult, pool1	10029-101E2	474.68	8.59	1.88	1.39	0.57
trachea, fetal, donor1	10058-101H4	364.31	8.08	1.54	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	565.42	7.79	8.15	1.06	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	87.23	4.96	0.61	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	161.54	5.01	0.78	2.98	0.31
tridermal teratoma cell line:HGRT	10694-109G1	439.48	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	384.14	15.74	5.93	2.62	1.86
umbilical cord, fetal, donor1	10057-101H3	310.89	2.09	0.00	4.17	0.00
uterus, adult, pool1	10100-102D1	482.54	11.60	0.51	0.85	0.34
uterus, fetal, donor1	10055-101H1	323.54	12.29	1.02	1.02	0.51
vagina, adult	10204-103F6	268.17	1.29	0.00	1.94	0.00
vein, adult	10191-103E2	206.05	3.73	0.22	0.88	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	0.00	0.00	0.53	0.00